Curis (CRIS) Net Margin (QoQ) (2010 - 2025)
Curis (CRIS) Net Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Curis | 3.48 Mn | -2.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 194,424.00 |
| Sep 30, 2025 | 6,923.00 |
| Jun 30, 2025 | 13,346.00 |
| Mar 31, 2025 | -14,336.00 |
| Dec 31, 2024 | 6,039.00 |
| Sep 30, 2024 | 11,653.00 |
| Jun 30, 2024 | 13,208.00 |
| Mar 31, 2024 | -18,974.00 |
| Dec 31, 2023 | 3,290.00 |
| Sep 30, 2023 | 12,699.00 |
| Jun 30, 2023 | -5,537.00 |
| Mar 31, 2023 | -16,686.00 |
| Dec 31, 2022 | 11,097.00 |
| Sep 30, 2022 | 20,664.00 |
| Jun 30, 2022 | 12,642.00 |
| Mar 31, 2022 | -36,412.00 |
| Dec 31, 2021 | -7,411.00 |
| Sep 30, 2021 | 14,989.00 |
| Jun 30, 2021 | -5,145.00 |
| Mar 31, 2021 | -38,080.00 |